XBIT

XBiotech Inc

5.39
-0.11 (-2.0%)

XBiotech Inc. (XBIT) Fundamentals

XBiotech Inc is a United States based clinical-stage biopharmaceutical company. It is engaged in discovering and developing True Human (antibody technology) monoclonal antibodies for treating a variety of diseases. The company focuses on developing Anti-IL-1 a therapeutic antibody as a treatment for cancer. Geographically, all of its operations are in the United States.
SHARE INFORMATION
Market CapUS$ 167,416,013
Shares Outstanding30,439,275
Float18,620,000
Percent Float61.17%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per ShareUS$ 0.00
Latest Fiscal RevenueUS$ 0
Latest Fiscal EPSUS$ -0.13
Latest Fiscal Date2023-03-31
DIVIDENDS
Dividend (3 Years)US$ 0.00
Dividend (5 Years)US$ 0.00
Ex Dividend Date-
Dividend RateUS$ 0.00
Dividend Yield0.0%
Payment CashCash
HOLDERS
Institutions166
Institutional Holdings Date2023-03-31
Institutional Bought Previous 3 Months53,722
Institutional Holdings Percent18.7%
Institutional Sold Previous 3 Months1,791,857
Insider Holdings Date2023-03-31
Insider Bought Previous 3 Months-
Insider Holdings Percent0.0
Insider Sold Previous 3 Months-
Insider Shares Owned-
TRADING INFO
52 Week HighUS$ 6.49
52 Week LowUS$ 3.00
52 Week High ChangeUS$ -7.87
21 Day Moving AverageUS$ 4.8057
21 Day Extended Moving AverageUS$ 4.916
50 Day Moving AverageUS$ 4.0186
50 Day Extended Moving AverageUS$ 4.3164
200 Day Moving AverageUS$ 3.7474
200 Day Extended Moving AverageUS$ 4.4603
10 Day Average Volume105,048
20 Day Average Volume208,639
30 Day Average Volume146,709
50 Day Average Volume100,008
Alpha0.013094
Beta1.2147
Standard Deviation0.198781
R20.107878
7 Day Price ChangeUS$ 0.58
7 Day Percent Change11.79%
21 Day Price ChangeUS$ 0.46
21 Day Percent Change9.13%
30 Day Price ChangeUS$ 2.21
30 Day Percent Change67.17%
Month to Date Price ChangeUS$ 0.405
Month to Date Percent Change7.95%
Quarter to Date Price ChangeUS$ 2.05
Quarter to Date Percent Change59.42%
180 Day Price ChangeUS$ 2.33
180 Day Percent Change73.5%
200 Day Price ChangeUS$ 2.10
200 Day Percent Change61.76%
Year to Date Price ChangeUS$ 1.99
Year to Date Percent Change56.7%

XBiotech Inc. (XBIT) Key Ratios

PROFITABILITY
EBIT Margin-860.7%
EBITDA Margin-793.9%
Pre-Tax Profit Margin942.2%
Profit Margin Count0.0%
Gross Margin87.5%
Profit Margin TOT0.0%
INCOME STATEMENTS
RevenueUS$ 0
Revenue Per ShareUS$ 0.00
Revenue (3 Years)US$ 0.00
Revenue (5 Years)US$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book0.00
Total Debt To Equity0.00
Int Coverage0.00
Current Ratio59.80
Leverage Ratio1.00
Quick Ratio58.80
Long Term Debt To Capital0.00
VALUATION MEASURES
PE Ratio0.00
Enterprise ValueUS$ -57,117,305
Price to Sales48.56
Price to Free Cash0.00
PE High Last 5 Years0.00
Price To Book0.00
Price To Cash Flow0.00
PE Low Last 5 Years0.00
Price to Tangible Book0.00
MANAGEMENT EFFECTIVENESS
Receivables Turnover14.00
Invoice Turnover0.00
Assets Turnover0.00
Return Assets-12.21
Return on Equity-6.81
Return on Capital-12.16

XBiotech Inc. (XBIT) Profile

PROFILE INFO
Issue TypeCS
SEC TypeEQS
Auditor-
CEOJohn Simard
Employees96
Last Audit-
CIK0001626878
IndustryBiotechnology
SectorHealthcare
NAICSPharmaceutical Preparation Manufacturing(325412)
CONTACT INFO
Address5217 Winnebago Lane
Austin, TX 78744
Websitehttp://www.xbiotech.com
Facsimile+1 512 386-5505
Telephone+1 512 386-2900
Emailaotero@xbiotech.com
Your Recent History
NASDAQ
XBIT
XBiotech
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to ADVFN
Register Now
NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

Support: 1-888-992-3836 | help@advfn.com

V: au D: 20230610 14:25:54